"Ecstasy" associated deaths: what is a fatal concentration ? Analysis of a case series

C M Milroy1

  • 1Eastern Ontario Forensic Pathology, Unit of the Ontario Forensic Pathology Service, Division of Anatomical Pathology, The Ottawa Hospital, 501 Smyth Road, Ottawa, ON, K2A 2L4, Canada. cmilroy@toh.on.ca

Insights

3,4-methylenedioxymethamphetamine (MDMA), or ecstasy, is linked to various fatal mechanisms. Blood MDMA concentrations in fatal cases overlap significantly, meaning no single level determines death. Autopsy findings and case history are crucial for accurate assessment.

Area of Science:

  • Forensic Toxicology
  • Pharmacology
  • Clinical Toxicology

Background:

  • 3,4-methylenedioxymethamphetamine (MDMA), a popular recreational amphetamine derivative, is associated with multiple causes of death.
  • These mechanisms include hyperpyrexia, cardiac arrhythmias, water intoxication, and liver failure.

Purpose of the Study:

  • To review fatal cases involving MDMA detection.
  • To analyze blood MDMA concentrations in relation to cause of death (MDMA toxicity, polydrug use, trauma).

Main Methods:

  • Retrospective review of 77 deaths where MDMA was detected in body fluids or organs.
  • Analysis of blood MDMA concentrations in cases of direct toxicity, polydrug use, and trauma.

Main Results:

  • MDMA was present in blood in 59 of the 77 reviewed deaths.
  • In 13 cases, death was attributed to MDMA toxicity alone (blood range: 0.478-53.9 mg/L).
  • In 22 cases of polydrug use, MDMA blood levels ranged from 0.04-41.5 mg/L.
  • In 24 trauma-related deaths, MDMA blood levels ranged from 0.035-4.81 mg/L.
  • Significant overlap in MDMA concentrations was observed between direct toxicity and trauma-associated deaths.

Conclusions:

  • No specific blood MDMA concentration can definitively determine death.
  • Accurate determination of cause of death requires consideration of autopsy findings and clinical history.
  • MDMA's role in fatalities, especially those involving trauma, necessitates comprehensive toxicological and forensic evaluation.

Related Concept Videos

Pharmacodynamic Models: Linear Concentration–Effect Model01:15

Pharmacodynamic Models: Linear Concentration–Effect Model

The linear concentration–effect model, underpinned by the principle that pharmacological effect (E) is directly proportional to plasma drug concentration (C), emerges as a pivotal simplification of the Emax model for conditions where C is significantly less than EC50. This model portrays a linear trajectory of the concentration–effect relationship when drug levels are markedly below the EC50 threshold.Despite its inherent assumption of continuous effect augmentation with increasing drug...
Drug Concentration Versus Time Correlation01:15

Drug Concentration Versus Time Correlation

The plasma drug concentration-time curve is a crucial tool in pharmacokinetics, representing the drug's concentration in plasma at different time intervals post-administration. This curve illustrates the drug's journey from absorption into the systemic circulation, distribution to body tissues, and eventual elimination through excretion or biotransformation.
Two pivotal parameters are the minimum effective concentration (MEC) and the minimum toxic concentration (MTC). The MEC is the lowest drug...
Pharmacodynamic Models: Emax Drug–Concentration Effect Model01:18

Pharmacodynamic Models: Emax Drug–Concentration Effect Model

The Emax drug-concentration effect model is central to pharmacodynamics in drug discovery and development. This model is predicated on the receptor occupancy theory, which posits that the effect of a drug is directly related to the number of receptors occupied by the drug and the resultant complex formation.The model describes the reversible interaction between a drug (C) and a receptor (R) to form a drug-receptor complex (RC). The kinetics of this interaction are quantified by an equation that...
Drug Toxicity: Dose-Dependent Reactions01:24

Drug Toxicity: Dose-Dependent Reactions

Drug toxicities can be stratified into pharmacological, pathological, or genotoxic based on their mechanisms. The incidence and severity of these toxicities generally increase with the drug's concentration in the body and exposure time.Pharmacological toxicity is evident when the therapeutic effects of drugs overshoot into adverse reactions in a predictable, dose-dependent manner. Central nervous system (CNS) depression from barbiturates is a classic example, with effects escalating from...
Drug Concentrations: Measurements01:23

Drug Concentrations: Measurements

Drug concentration is the quantity of a drug present in a biological sample. Measuring drug amounts in biological samples allows the clinician to understand how a drug is absorbed, distributed, metabolized, and excreted. Samples can be obtained through invasive or non-invasive methods. Invasive techniques involve surgical or parenteral interventions to gather blood, cerebrospinal fluid, or tissue biopsy. Conversely, non-invasive approaches provide samples like urine, feces, and saliva.
Plasma —...
Toxidromes: Clinical Features01:30

Toxidromes: Clinical Features

Toxidromes are specific patterns of symptoms resulting from toxic substance exposure. They help in the identification and treatment of poisoning. The symptoms of each toxidrome group indicate poisoning by a certain class of chemicals or drugs.1. Sympathomimetic: Stimulates the sympathetic nervous system. Symptoms include agitation, increased heart rate (HR), blood pressure (BP), respiratory rate (RR), temperature, and pupil size. Drugs like cocaine and amphetamines, along with tremors and...